Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Active not recruiting × abiraterone × Clear all

Phase

Phase 2 6 Phase 3 4 Phase EARLY_PHASE1 1 Phase 2/3 1 Phase 1 1

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Paclitaxel 11 Cyclophosphamide 10 Doxorubicin 9 Cisplatin 8 Prednisone 7 Oxaliplatin 7 Docetaxel 7 Magnetic Resonance Spectroscopy 6 Etoposide 6 Carboplatin 6 Capecitabine 6 Vincristine 5 Specimen Handling 5 Leucovorin 5 pembrolizumab 4 Trastuzumab 4 Radiotherapy 4 Gemcitabine 4 Fluorouracil 4 Cytarabine 4 Bevacizumab 4 atezolizumab 3 Watchful Waiting 3 Taxes 3 Rituximab 3 Ramucirumab 3 Radiation 3 Epirubicin 3 Dexamethasone 3 Calcium Dobesilate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00268476 2023-04-18

STAMPEDE

Medical Research Council

Phase 2/3 Active not recruiting

11,992 enrolled

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡